Methyl 4-aminobicyclo[2.2.2]octane-1-carboxylate hydrochloride, 95.0%, 500mg

2-Hydroxy-N,N,N-trimethylethan-1-aminium (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate, 98.0%, 50mg

Benzenemethanamine, 3-fluoro-, hydrochloride, 98%, 1g

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)

2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-6-amine, 95%, 250mg

Pair of eyecups, Ø 30 mm tube

2-(1H-Imidazol-2-yl)aniline hydrochloride, 95.0%, 5g

tert-Butyl 5-bromo-3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate, 95.0%, 1g

5-BROMO-2-FLUOROPYRIDIN-4-OL, 95.0%, 250mg

(R)-1-(Thiazol-2-yl)ethanol, 97%, 100mg

ETHYL 1,2,3,6-TETRAHYDROPYRIDINE-4-CARBOXYLATE HCL, 95.0%, 250mg

1-Methyl-5-(methylsulfanyl)-1H-[1,2,4]-triazol-3-yl amine, 95.0%, 5g

2,4-Dibromopyridine, 97.0%, 1g